Target intelligence / Profile preview

TPBGL antisense RNA 1 (TPBGL-AS1)

Target
TPBGL-AS1
Molecular classification
Long non-coding RNA, antisense RNA
01

Overview

TPBGL antisense RNA 1 (TPBGL-AS1) is a long non-coding RNA transcript mapped in the NCBI Gene database (Accession: 105369388). There is no available evidence for its physiological function, role as a drug target, aliases, or involvement in disease. In the context of functional studies or drug development, antisense lncRNAs are recognized for their ability to regulate gene expression by forming RNA duplexes with sense mRNAs, recruiting chromatin-modifying proteins, and acting as competing endogenous RNAs in disease (not specifically for TPBGL-AS1). Current evidence suggests TPBGL-AS1 is a catalogued non-coding RNA gene, but there is insufficient data to classify it as a drug or biomarker target, or assign aliases and functional roles. The information about this molecule is sparse, so any structured annotation will be limited.

02

Mechanism of action

None reported for TPBGL-AS1; antisense lncRNAs can modulate gene expression through chromatin modification, promoter competition, or as competing endogenous RNAs (ceRNA)

03

Biological functions

Unclear for TPBGL-AS1 specifically; generally for antisense lncRNAs, functions include regulation of gene expression (epigenetic, transcriptional, post-transcriptional, translational)chromatin remodelinggene silencing
04

Disease associations

None specific to TPBGL-AS1. For antisense lncRNAs generally, possible roles in cancer (oncogenesis/tumor suppression)imprinting disordersepigenetic diseases
05

Safety considerations

None specifically noted for TPBGL-AS1. For antisense oligonucleotide therapeutics, general concerns include off-target effects and immunogenicity
06

Biomarkers

None reported for TPBGL-AS1. Generally, antisense lncRNAs may serve as cancer biomarkers

Beyond the preview

Go deeper on TPBGL antisense RNA 1 (TPBGL-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TPBGL antisense RNA 1 (TPBGL-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call